New York Eye and Ear Infirmary
New York, 10003, United States
NCT Number: NCT02244671
immobilization of yoked extra-ocular muscles in the anophthalmic orbit, in conjunction with platelet-rich-plasma, will improve integration of viable adipocytes injected into orbital fat
Looking for future studies?
Notify Me21 year–75 year
All sexes
Interventional
Not applicable
New York, 10003, United States
Immobilization of tissue (graft, graft bed) is a prerequisite for tissue integration. Since yoked extra-ocular muscles continue to be stimulated by movements of the seeing eye after fat injection into the anophthalmic orbit, the use of botulinum toxin(s) can be used to prevent movement of the orbital tissue bed(s) and improve anchoring of injected fat. Platelet rich plasma may also improve fat cell anchoring by the action of fibrin on the adhesion process. This innovation builds on the results of IRB protocols 10.27 and 12.01 as registered with Clinical Trials.gov
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
fat injection with platelet-rich-plasma (PRP) after immobilizing the extraocular muscles with botulinum toxin
Other names: fat atrophy, absence of original eye, phthisis bulbi
botulinum toxin used to immobilize extra-ocular muscles prior to fat injection.
Other names: botulinum toxins
autologous PRP is prepared with a dedicated centrifuge at the time of fat harvesting
Other names: platelet rich plasma
Time frame: one year
Augmentation of orbital volume accessed with clinical photographs and non-contrast MRI
Fox, Donald Munro, M.D., P.C.
Indiv
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01712555
Anophthalmos, Congenital Abnormalities
New York, United States
View Trial Details